Fasting plasma glucose (FPG) levels, fasting insulin levels, and homeostasis model assessment-insulin resistance (HOMA-IR) were higher in NAFLD subjects than in non-NAFLD subjects in the young-age and middle-age groups. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.